Información de la revista
Lo más leído
772
Fibrosis avanzada asociada a esteatohepatitis no alcohólica (NASH) en España: resultados de un estudio DelphiRocío Aller, José Luis Calleja, Javier Crespo, Manuel Romero-Gómez, Juan Turnes, Omar J. Benmarzouk-Hidalgo, Rafael Subirán, Alicia Gil
Gastroenterol Hepatol. 2024;47:337-46
772
589
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCUMar Riveiro-Barciela, Sabela Carballal, Álvaro Díaz-González, Míriam Mañosa, Javier Gallego-Plazas, Joaquín Cubiella, Paula Jiménez-Fonseca, María Varela, ... María-Carlota Londoño
Gastroenterol Hepatol. 2024;47:401-32
589
416
Postcolonoscopy colorectal cancer: Prevalence, categorization and root-cause analysis based on the World Endoscopic Organization systemAntonio Z. Gimeno-García, Anjara Hernández-Pérez, Federica Benítez, Noemi Segura, David Nicolás-Pérez, Enrique Quintero, Noemi Hernández-Álvarez, Isabel Betancor, ... Manuel Hernández-Guerra
Gastroenterol Hepatol. 2024;47:319-26
416
380
Glomerulonefritis fibrilar extrarrenal como nueva etiología de enfermedad hepática avanzadaCarlos Alventosa Mateu, Ana Vilar Gimeno, Irene Pérez Álvarez, Javier Carbonell Zamorano, Inmaculada Castelló Miralles, Mercedes Latorre Sánchez, Juan José Urquijo Ponce, Encarnación Martínez Leandro, ... Moisés Diago
Gastroenterol Hepatol. 2024;47:381-3
380
366
Vinpocetine represses the progression of nonalcoholic steatohepatitis in mice by mediating inflammasome components via NF-κB signalingYingwei Zhu, Hong Tang, Han Zhao, Jian Lu, Kai Lin, Jingbin Ni, Bo Zhao, Gaojue Wu, Chunxiao Tan
Gastroenterol Hepatol. 2024;47:366-76
366
320
Quiste de duplicación entérica como presentación poco frecuente de abdomen agudo en adultoGerard Rafart, Clara Bassaganyas, Xavier Morales, Míriam Cuatrecasas, Jordi Rimola
Gastroenterol Hepatol. 2024;47:389-90
320
288
MSH3-related adenomatous polyposis in a patient with the negative family history of colorectal polypsAleksandar Gavric, Mateja Krajc, Luka Strnisa, Ana Ursula Gavric, Samo Plut
Gastroenterol Hepatol. 2024;47:397-400
288
264
What shall we do with yellowish rectal lesions during screening colonoscopy?Vincent Zimmer
Gastroenterol Hepatol. 2024;47:387-8
264
252
Impact of biliary stents in the performance of the EUS-guided tissue acquisition: A systematic review and meta-analysisEdson Guzmán-Calderón, Alfonso Chacaltana, Carlos Díaz-Arocutipa, Ramiro Díaz, Ronald Arcana, José Ramón Aparicio
Gastroenterol Hepatol. 2024;47:327-36
252
245
MASLD biomarkers: Are we facing a new era?Douglas Maya-Miles, Javier Ampuero, David Martí-Aguado, Andrés Conthe, Rocío Gallego-Durán
Gastroenterol Hepatol. 2024;47:393-6
245
234
Beyond Crohn's disease: Deferasirox as possible agent for drug-induced ileocolitisEsteban Fuentes-Valenzuela, Ana Yaiza Carbajo, Samuel Juan Fernández-Prada, Beatriz Madrigal Rubiales, Natalia Carpizo Jimenez
Gastroenterol Hepatol. 2024;47:380-1
234
207
Endoscopic resection of a large symptomatic duodenal lipomaLuka Strnisa, Samo Plut, Sasa Golob, Aleksandar Gavric
Gastroenterol Hepatol. 2024;47:384-6
207
203
An in vitro analysis of the interaction between infliximab and granulocyte–monocyte apheresisIago Rodríguez-Lago, Leticia Abecia, Iratxe Seoane, Juan Anguita, José Luis Cabriada
Gastroenterol Hepatol. 2024;47:347-51
203
201
Recurrent skin reaction at the site of former subcutaneous injection after switching back to intravenous vedolizumabFiorella Cañete, Laura Gonzalez-Gonzalez, Eugeni Domènech
Gastroenterol Hepatol. 2024;47:377-8
201
197
Carcinoma medular gástrico: una variante histológica muy infrecuenteDavid Hernandez Bermejo, Silvia Carbonell Morote, Cristina Alenda, Sergio Ortiz, Ester Gracia, Emilio Ruiz de la Cuesta, Jose Luis Estrada, Jose Manuel Ramia
Gastroenterol Hepatol. 2024;47:378-9
197
180
Rspo2-LGR4 exacerbates hepatocellular carcinoma progression via activation of Wnt/β-catenin signaling pathwayYanghui Bi, Liping Zhang, Yan Song, Lijun Sun, Michael W. Mulholland, Yue Yin, Weizhen Zhang
Gastroenterol Hepatol. 2024;47:352-65
180
166
Ischemic colitis due to Kayexalate crystalsBerta Lopez-Saez, Alex Casalots, Eva Ballesteros, Eduard Brunet-Mas
Gastroenterol Hepatol. 2024;47:391-2
166